PX-102

DB15416InvestigationalSmall molecule

PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study With Px-102).

Chemical structure of PX-102
Mechanism
Curator reviewed
Formula / weight
C29H22Cl3NO4 · 554.85 g/mol (avg)
Code names
PX-102

Resolves to

Compound
UNII378SU5NO8SCAS1268244-88-7ChEMBLCHEMBL3822773
Structure
InChIKeyXBUXXJUEBFDQHD-NHCUHLMSSA-NSMILESOC(=O)C1=CC=C(C=C1)[C@H]1C[C@@H]1C1=C(Cl)C=C(OCC2=C(ON=C2C2=C(Cl)C=CC=C2Cl)C2CC2)C=C1
Targets
Q96RI1NR1H4

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PX-102, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In